Mainstream

Neurocrine refines INGREZZA net sales guidance to $2.5B-$2.55B while CRENESSITY surges, driving revenue growth and pipeline expansion

Neurocrine refines INGREZZA net sales guidance to $2.5B-$2.55B while CRENESSITY surges, driving revenue growth and pipeline expansion

Post ContentnbixRead More

You might also be interested in reading China launches $500 annual baby subsidy in bid to boost births.

July 31, 2025
In Mainstream